rs147508369
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4BS1_SupportingBS2
The NM_001022.4(RPS19):c.164C>T(p.Thr55Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000491 in 1,613,126 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T55T) has been classified as Likely benign.
Frequency
Consequence
NM_001022.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPS19 | NM_001022.4 | c.164C>T | p.Thr55Met | missense_variant | 3/6 | ENST00000598742.6 | |
RPS19 | NM_001321485.2 | c.164C>T | p.Thr55Met | missense_variant | 3/6 | ||
RPS19 | NM_001321483.2 | c.164C>T | p.Thr55Met | missense_variant | 3/6 | ||
RPS19 | NM_001321484.2 | c.164C>T | p.Thr55Met | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPS19 | ENST00000598742.6 | c.164C>T | p.Thr55Met | missense_variant | 3/6 | 1 | NM_001022.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000361 AC: 55AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000247 AC: 62AN: 251298Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135848
GnomAD4 exome AF: 0.000504 AC: 737AN: 1460934Hom.: 1 Cov.: 30 AF XY: 0.000469 AC XY: 341AN XY: 726842
GnomAD4 genome ? AF: 0.000361 AC: 55AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74352
ClinVar
Submissions by phenotype
Diamond-Blackfan anemia 1 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 06, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 06, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 07, 2020 | - - |
Hepatoblastoma Uncertain:1
Uncertain significance, no assertion criteria provided | research | Molecular Oncology - Human Genetics Lab, University of Sao Paulo | - | - - |
Diamond-Blackfan anemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 21, 2023 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 55 of the RPS19 protein (p.Thr55Met). This variant is present in population databases (rs147508369, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with Diamond-Blackfan anemia (PMID: 12586610). ClinVar contains an entry for this variant (Variation ID: 242753). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change does not substantially affect RPS19 function (PMID: 12586610). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at